Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...

A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase ...

Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.

People started on a low dose of Amgen's long-acting experimental obesity drug MariTide lost as much weight as those given ...

A new weight loss pill currently undergoing clinical trials could help burn fat and lower blood sugar levels like Ozempic and ...

Doctors say there have been a number of developments with new weight loss drugs, which could make them easier for patients to ...

Amgen shares fell sharply on Monday afternoon after the company released results from a weight-loss trial that showed that ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

Patients who took an experimental drug from Eli Lilly & Co. together with Novo Nordisk A/S’s Wegovy maintained muscle while ...

Omnicom's $13.5 billion acquisition of rival Interpublic can move forward on the condition the new company does not enter ...

Drugmakers are racing to develop the next wave of obesity and diabetes medications that they hope will be even more powerful ...

GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...